Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,439 | -21,698 | -15,596 | -8,230 | -24,384 |
| Depreciation Amortization | 365 | 115 | 6 | 2 | 61 |
| Accounts receivable | 2,060 | -972 | -893 | -236 | 98 |
| Other Working Capital | 2,702 | 3,967 | 1,653 | 195 | -391 |
| Other Operating Activity | 382 | 3,992 | 3,459 | 861 | 23,027 |
| Operating Cash Flow | $-23,930 | $-14,595 | $-11,371 | $-7,408 | $-1,589 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,481 | N/A | N/A | N/A | N/A |
| PPE Investments | -733 | -1,178 | -52 | N/A | -1 |
| Investing Cash Flow | $-7,214 | $-1,178 | $-52 | $N/A | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 200 |
| Common Stock Issued | 107,524 | 15,949 | 15,698 | 3,389 | 18,649 |
| Common Stock Repurchased | N/A | N/A | N/A | -100 | N/A |
| Other Financing Activity | -137 | 0 | -235 | -57 | 0 |
| Financing Cash Flow | $107,387 | $15,949 | $15,464 | $3,232 | $18,849 |
| Exchange Rate Effect | 4 | -4 | 33 | -32 | -5 |
| Beginning Cash Position | 17,682 | 17,510 | 13,437 | 17,645 | 391 |
| End Cash Position | 93,929 | 17,682 | 17,510 | 13,437 | 17,645 |
| Net Cash Flow | $76,247 | $172 | $4,073 | $-4,208 | $17,253 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,930 | -14,595 | -11,371 | -7,408 | -1,589 |
| Capital Expenditure | -733 | -1,178 | -52 | N/A | -1 |
| Free Cash Flow | -24,663 | -15,773 | -11,424 | -7,408 | -1,590 |